Laron syndrome with immunodeficiency (Q88878): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Síndrome de Laron com imunodeficiência é caracterizada por retardo grave de crescimento pós-natal, atraso de idade óssea e dismorfismo facial (testa proeminente, ponte nasal hipoplásica), e baixa concentração sérica de IGF-1 com concentrações normal ou elevada de hormônio do crescimento (GH), associada com imunodeficiência caracterizada por moderada linfopenia, o que leva a infecções recorrentes da pele e do trato respiratório.
description / endescription / en
 
Laron syndrome with immunodeficiency is characterised by severe post-natal growth retardation, delayed bone age and facial dysmorphism (prominent forehead, hypoplastic nasal bridge), and low serum IGF-1 concentrations with normal or high GH concentrations, associated with immunodeficiency characterised by moderate lymphopenia which leads to recurrent infections of the skin and respiratory tract.

Revision as of 15:16, 15 August 2026

Laron syndrome with immunodeficiency is characterised by severe post-natal growth retardation, delayed bone age and facial dysmorphism (prominent forehead, hypoplastic nasal bridge), and low serum IGF-1 concentrations with normal or high GH concentrations, associated with immunodeficiency characterised by moderate lymphopenia which leads to recurrent infections of the skin and respiratory tract.
Language Label Description Also known as
default for all languages
ID_142511578
    English
    Laron syndrome with immunodeficiency
    Laron syndrome with immunodeficiency is characterised by severe post-natal growth retardation, delayed bone age and facial dysmorphism (prominent forehead, hypoplastic nasal bridge), and low serum IGF-1 concentrations with normal or high GH concentrations, associated with immunodeficiency characterised by moderate lymphopenia which leads to recurrent infections of the skin and respiratory tract.

      Statements